JCI标准下某医院麻醉药品使用情况分析

发布时间：2018-03-16 11:19

本文选题：JCI　切入点：麻醉药品　出处：《中国药物依赖性杂志》2016年05期 　论文类型：期刊论文

【摘要】：目的:分析JCI标准下新疆医科大学第一附属医院(以下简称"我院")麻醉药品使用情况,为临床合理用药提供参考依据。方法:对我院2014-2015年使用的麻醉药品进行统计、汇总,采用用药频度(DDDs)、日均费用(DDC)及购药金额排序(B)与DDDs排序(A)的排序比(B/A)为指标对用药情况进行分析。结果:JCI认证后我院麻醉药品用量和销售金额呈现增长趋势;0.5 mg枸橼酸芬太尼注射液DDDs两年均占据首位;舒芬太尼注射液、注射用瑞芬太尼、羟考酮缓释片、芬太尼透皮贴剂DDDs较JCI前均有不同程度的增加;0.5 mg枸橼酸芬太尼注射液排序比为3,具有良好的药物经济学。结论:JCI标准下我院麻醉药品使用基本合理,但仍需严格管控,使之更加安全、有效地应用于临床。
[Abstract]:Objective: to analyze the use of narcotic drugs in the first affiliated Hospital of Xinjiang Medical University (hereinafter referred to as "our hospital") under the JCI standard, and to provide a reference for the rational use of drugs in clinic. The drug usage was analyzed by using the order ratio of DDDsC, daily average cost, sum of money purchased and DDDs sequencing A). Results the dosage and sales amount of narcotic drugs in our hospital showed an increasing trend of 0.5 mg after the certification of the President JCI. Fentanyl citrate injection DDDs occupied the first place in two years. Sufentanil injection, remifentanil for injection, hydroxycodone sustained release tablets, The sequence ratio of fentanyl transdermal patch DDDs was 3, which was better than that before JCI. Conclusion the use of narcotic drugs in our hospital under the standard of DDDs is reasonable, but it still needs to be strictly controlled. To make it more safe and effective in clinical application.
【作者单位】：新疆医科大学第一附属医院药学部;
【分类号】：R971.2

【相似文献】